Related Experiment Video
Updated: Jun 5, 2026

06:19
Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Generalist large language models complement tailor-made predictors for tumor genomics interpretation
Biorxiv : the Preprint Server for Biology
|June 4, 2026
Summary
General-purpose large language models (LLMs) show promise in clinical genomic interpretation. They can augment existing models for tasks like distinguishing tumor mutations and inferring cancer type, improving diagnostic accuracy.
Area of Science:
- Genomics
- Artificial Intelligence
- Computational Biology
Background:
- Large language models (LLMs) possess broad knowledge but their utility in specialized medical tasks is uncertain.
- Clinical genomic interpretation involves complex data analysis for accurate diagnosis and treatment.
Purpose of the Study:
- To evaluate the performance of general-purpose LLMs on three key clinical tumor genomic interpretation tasks.
- To determine if LLMs can replace or augment existing task-specific predictive models.
Main Methods:
- LLMs were assessed on distinguishing tumor vs. non-tumor mutations, driver vs. passenger mutations, and inferring cancer type from sequencing reports.
- Performance was compared against benchmark tailor-made models and evaluated on out-of-distribution data.
Main Results:
- General-purpose LLMs matched benchmark performance for tumor mutation identification.
- Ensembling LLMs with tailor-made models enhanced performance for mutation classification.
- LLMs showed superior or supplementary performance for cancer type inference on novel data.
Conclusions:
- Current LLMs offer valuable complementary expertise for clinical genomic interpretation without fine-tuning.
- LLMs can augment state-of-the-art predictors, improving the accuracy and scope of genomic analysis in oncology.
Related Concept Videos
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...